Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cellular Signalling|July 26, 2019
Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytesKonstantina Stathopoulou, Sophie Schobesberger, Nadja I Bork, et al.
The Journal of Biological Chemistry|November 28, 2013
Phosphoregulation of the titin-cap protein telethonin in cardiac myocytesAlexandra J Candasamy, Robert S Haworth, Friederike Cuello, et al.
Journal of Molecular and Cellular Cardiology|April 3, 2012
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in miceBodvaël Fraysse, Florian Weinberger, Sonya C Bardswell, et al.
Basic Research in Cardiology|January 20, 2011
Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytesKarina Grube, Julia Rüdebusch, Zhelong Xu, et al.
Molecular & Cellular Proteomics : MCP|June 25, 2014
Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsisFriederike Cuello, Manu Shankar-Hari, Ursula Mayr, et al.
Plos One|November 28, 2018
Correction: Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart TissueFabian Jacob, Amina Y Yonis, Friederike Cuello, et al.
Plos One|February 4, 2016
Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart TissueFabian Jacob, Amina Y Yonis, Friederike Cuello, et al.
Matrix Biology Plus|October 4, 2022
Extracellular Matrix Profiling and Disease Modelling in Engineered Vascular Smooth Muscle Cell TissuesElla Reed, Adam Fellows, Ruifang Lu, et al.
Redox Biology|April 8, 2021
Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissueAlexandra Rhoden, Felix W Friedrich, Theresa Brandt, et al.
Cardiovascular Research|November 5, 2015
Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathyFrederik Flenner, Felix W Friedrich, Nele Ungeheuer, et al.
Pageof 6